CRL
Charles River Laboratories International Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$155.46
+2.80 ▲ +1.83%
🌙 3월 13일 7:47 PM ET (한국 3/14 08:47)
$154.29
-1.17 ▼ -0.75%
| Index | S&P 500 | P/E | - | EPS (ttm) | -2.96 | Insider Own | 1.26% | Shs Outstand | 0.05B | Perf Week | -10.89% |
| Market Cap | 7.65B | Forward P/E | 12.91 | EPS next Y | 8.77% | Insider Trans | -0.06% | Shs Float | 0.05B | Perf Month | -6.34% |
| Enterprise Value | 10.12B | PEG | 1.49 | EPS next Q | 1.93 | Inst Own | 108% | Short Float | 7.28% | Perf Quarter | -20.22% |
| Income | -0.14B | P/S | 1.91 | EPS this Y | 7.67% | Inst Trans | 5.1% | Short Ratio | 3.83 | Perf Half Y | -2.68% |
| Sales | 4.02B | P/B | 2.42 | EPS next 5Y | 8.65% | ROA | -1.97% | Short Interest | 3.54M | Perf YTD | -22.07% |
| Book/sh | 64.3 | P/C | 35.69 | EPS past 3/5Y | - | ROE | -4.36% | 52W High | -32.08% ($228.88) | Perf Year | -6.87% |
| Cash/sh | 4.36 | P/FCF | 14.76 | Sales past 3/5Y | 0.33% 6.55% | ROIC | -2.52% | 52W Low | 69.23% ($91.86) | Perf 3Y | -23.05% |
| Dividend Est. | - | EV/EBITDA | 11.19 | EPS Y/Y TTM | -1143.24% | Gross Margin | 30.52% | Volatility(W/M) | 5.29% 5.27% | Perf 5Y | -45.79% |
| Dividend TTM | - | EV/Sales | 2.52 | Sales Y/Y TTM | -0.85% | Oper. Margin | 12.48% | ATR (14) | 8.67 | Perf 10Y | 107.47% |
| Dividend Ex-Date | - | Quick Ratio | 1.02 | EPS Q/Q | -33.22% | Profit Margin | -3.59% | RSI (14) | 34.52 | Recom | 2.05 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.29 | Sales Q/Q | -0.83% | SMA20 | -7.83% ($168.67) | Beta | 1.68 | Target Price | $200.5 |
| Payout | - | Debt/Eq | 0.83 | Earnings | 2000000 | SMA50 | -19.03% ($192) | Rel Volume | 1.07 | Prev Close | $152.66 |
| Employees | 19700 | LT Debt/Eq | 0.81 | EPS/Sales Surpr. | 1.87% 0.73% | SMA200 | -9.95% ($172.64) | Avg Volume(3M) | 0.92M | Price | $155.46 |
| IPO | 2000/6/23 | Option/Short | Yes/Yes | Trades | 12812 | Volume | 987,596 | Change | 1.83% |
뉴스 로딩 중...